Genetic polymorphisms in CYP3A4 are associated with withdrawal symptoms and adverse reactions in methadone maintenance patients (Q50787650)

19 March 2018

title

Genetic polymorphisms in CYP3A4 are associated with withdrawal symptoms and adverse reactions in methadone maintenance patients (English)

1 reference

19 March 2018

1 reference

19 March 2018

Ya-Ting Hsu

0 references

Hsiao-Hui Tsou

0 references

Chia-Hui Chen

1 reference

19 March 2018

Sheng-Chang Wang

1 reference

19 March 2018

Ing-Kang Ho

1 reference

19 March 2018

Jia-Ni Tian

1 reference

19 March 2018

Cheng-Jou Yu

1 reference

19 March 2018

Sun-Yuan Chou

1 reference

19 March 2018

Yen-Feng Lin

1 reference

19 March 2018

Kai-Chi Fang

1 reference

19 March 2018

Chieh-Liang Huang

1 reference

19 March 2018

Lien-Wen Su

1 reference

19 March 2018

Yong-Chun Fang

1 reference

19 March 2018

Ming-Lun Liu

1 reference

19 March 2018

Keh-Ming Lin

1 reference

19 March 2018

Shu Chih Liu

1 reference

19 March 2018

Andrew Ch Chen

1 reference

19 March 2018

Yu-Li Liu

1 reference

19 March 2018

publication date

8 September 2011

1 reference

19 March 2018

published in

Pharmacogenomics

1 reference

19 March 2018

volume

1 reference

19 March 2018

issue

1 reference

19 March 2018

page(s)

1397-1406

1 reference

19 March 2018

Drug treatment as HIV prevention: expanding treatment options

cites work

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.103

Chiral analysis of methadone and its major metabolites (EDDP and EMDP) by liquid chromatography-mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.103

Stereoselective pharmacokinetics of methadone in chronic pain patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.103

Stereo-selective metabolism of methadone by human liver microsomes and cDNA-expressed cytochrome P450s: a reconciliation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.103

Role of CYP2B6 in stereoselective human methadone metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.103

Stereoselective metabolism of methadone N-demethylation by cytochrome P4502B6 and 2C19.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.103

Involvement of CYP3A4, CYP2C8, and CYP2D6 in the metabolism of (R)- and (S)-methadone in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.103

Methadone metabolism and clearance are induced by nelfinavir despite inhibition of cytochrome P4503A (CYP3A) activity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.103

Capillary electrophoresis to assess drug metabolism induced in vitro using single CYP450 enzymes (Supersomes): application to the chiral metabolism of mephenytoin and methadone

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.103

Genetic polymorphisms of cytochrome P450 enzymes influence metabolism of the antidepressant escitalopram and treatment response.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.103

Betel nut: a common drug used by naturalized citizens from India, Far East Asia, and the South Pacific Islands

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.103

Development of the Treatment Outcomes Profile

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.103

The Clinical Opiate Withdrawal Scale (COWS).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.103

Development of a method to measure methadone enantiomers and its metabolites without enantiomer standard compounds for the plasma of methadone maintenance patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.103

FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.103

Genotyping single nucleotide polymorphisms by MALDI mass spectrometry in clinical applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.103

Haploview: analysis and visualization of LD and haplotype maps

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.103

A comparison of bayesian methods for haplotype reconstruction from population genotype data

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.103

Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.103

Methadone--metabolism, pharmacokinetics and interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.103

Lack of an effect of atazanavir on steady-state pharmacokinetics of methadone in patients chronically treated for opiate addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.103

Role of hepatic and intestinal cytochrome P450 3A and 2B6 in the metabolism, disposition, and miotic effects of methadone

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.103

Actual and potential drug interactions associated with methadone

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.103

Selecting an appropriate medication for treating neuropathic pain in patients with diabetes: a study using the U.K. and Germany Mediplus databases.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.103

CYP2B6 polymorphisms influence the plasma concentration and clearance of the methadone S-enantiomer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.103

ABCB1 and cytochrome P450 genotypes and phenotypes: Influence on methadone plasma levels and response to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.103

Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.11.103

21 January 2018

Identifiers

DOI

10.2217/PGS.11.103

1 reference

19 March 2018

1 reference

19 March 2018